Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Viking Therapeutics soars on positive weight-loss drug results
09:07am, Tuesday, 27'th Feb 2024
Viking Therapeutics (NASDAQ:VKTX) Inc shares skyrocketed almost 80% on Tuesday morning after the firm unveiled positive results from a trial of its VK2735 weight loss drug. Patients receiving the trea
Viking Therapeutics stock jumps 80% after positive weight loss drug trial results
08:26am, Tuesday, 27'th Feb 2024
Analysts have suggested that larger pharmaceutical companies could potentially move to acquire a company like Viking Therapeutics.
Viking Therapeutics Stock Surges 100% on Positive Weight-Loss Drug Trial
08:04am, Tuesday, 27'th Feb 2024
Patients see ‘significant' reductions in body weight during a study of a weight-loss drug developed by Viking Therapeutics, the company says.
Viking Therapeutics' weight-loss drug succeeds in mid-stage study
07:16am, Tuesday, 27'th Feb 2024
Viking Therapeutics said on Tuesday its experimental drug to treat obesity helped achieve "significant" weight loss in a mid-stage study.
What's going on with the Viking Therapeutics (VKTX) stock price?
05:21am, Tuesday, 20'th Feb 2024
Viking Therapeutics (VKTX) stock price has silently emerged as one of the best-performing companies in Wall Street this year. It jumped by over 14% on Friday and is up by 1.20% in the pre-market sessi
The 3 Biotech Stocks That Could Make Your February Unforgettable
11:57am, Thursday, 15'th Feb 2024
Following a hot year of M&A with biotech stocks, we'll see more of the same in 2024 as drug makers look to build their pipelines ahead of a massive patent cliff. Between now and 2028, pharmaceutical g
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
02:43pm, Wednesday, 14'th Feb 2024
It is entirely fair to state that weight loss treatments have massive transformational power. US FDA approval of weight loss medicines could help shrink millions of waistlines.
Viking Therapeutics may offer investors a cheap entry to the weight-loss drug craze
02:18pm, Thursday, 08'th Feb 2024
Viking Therapeutics Inc.'s stock soared 17% to a record high on Thursday, after the company said it expects data from early and mid-stage trials of its weight-loss drug as soon as the first quarter, m
The 3 Most Undervalued Biotech Stocks to Buy in February 2024
01:15pm, Thursday, 08'th Feb 2024
With patience, some of the most undervalued biotech stocks can create massive wealth. Look at ACADIA Pharmaceuticals (NASDAQ: ACAD ), for example.
Viking Therapeutics, Inc. (VKTX) Q4 2024 Earnings Call Transcript
09:48pm, Wednesday, 07'th Feb 2024
Viking Therapeutics, Inc. (VKTX) Q4 2024 Earnings Call Transcript
MoneyShow's Best Investment Ideas For 2024: Part 9
09:30am, Tuesday, 06'th Feb 2024
MoneyShow presents top investment ideas for 2024 from their contributors. This year's edition presents a broad mix of conservative income stocks, more speculative but potentially more rewarding growth
The 3 Best Biotech Stocks to Invest in for Big Gains in 2024
02:15am, Friday, 02'nd Feb 2024
The quest for prime biotech stocks for gains will always be relevant. Moreover, 2024 promises a surge in technology and science, positioning biotech firms at the forefront of novel medical breakthroug
3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024
05:41pm, Monday, 22'nd Jan 2024
Biotech stocks are some of the most exciting opportunities on the market. Find the right ones with substantial catalysts and make a fortune.
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
03:40pm, Wednesday, 17'th Jan 2024
Wall Street has been focused on Novo Nordisk, Eli Lilly and other large drugmakers hoping to join the weight loss drug market, such as Pfizer, Roche and Amgen.
2 biotechs with promising weight-loss drugs coming
07:01am, Tuesday, 16'th Jan 2024
Clinical weight-loss medications have been making headlines. GLP-1 drugs like Novo Nordisk A/S NYSE: NVO owned Ozempic and Wegovy and Eli Lilly and Co. NYSE: LLY owned Mounjaro and Zepbound contin
